While people from all groups reduced their social interactions, those with higher incomes made greater changes to their behavior, according to a new study co-authored by a Cornell researcher.
Cornell researchers have helped develop a nasal formulation that blocks the spread of COVID-19 among ferrets – and are hopeful the formulation could have the same effect on humans, and potentially generate therapeutic treatments as well.
The Bronfenbrenner Center for Translational Research is launching a new project – the Community Neuroscience Initiative, or CNI – that will build connections between neuroscience, the social sciences and communities.
The discovery of an “Achilles’ heel” in a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease may lead to more targeted therapies for the difficult-to-treat disease, researchers have found.
The environment surrounding the cells of a lymphoma tumor has a strong influence on the progression of these blood-cell cancers and their responses to therapies, according to a new study by Weill Cornell Medicine investigators.
Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine.
Cornell and WWF will host a virtual conference Feb. 23 focused on the link between humans and wildlife, and the subsequent prevention of future pandemics.
A type of cell widely used for brain research and drug development may have been leading researchers astray for years, according to a study from scientists at Weill Cornell Medicine and Columbia University.
Poor function of the gene SMC3 can lead to improper immune cell development, and to cancer, by disrupting how DNA is structured inside the cell nucleus, according to new research from Weill Cornell Medicine.
